Ikarian Capital’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-90,837
| Closed | -$3.14M | – | 109 |
|
|
2025
Q1 | $3.14M | Sell |
90,837
-124,876
| -58% | -$4.32M | 0.39% | 33 |
|
|
2024
Q4 | $5.92M | Sell |
215,713
-69,900
| -24% | -$1.92M | 0.81% | 18 |
|
|
2024
Q3 | $7.27M | Sell |
285,613
-46,400
| -14% | -$1.18M | 1.01% | 15 |
|
|
2024
Q2 | $8.41M | Buy |
332,013
+50,000
| +18% | +$1.27M | 1.47% | 11 |
|
|
2024
Q1 | $8.72M | Sell |
282,013
-191,113
| -40% | -$5.91M | 0.96% | 13 |
|
|
2023
Q4 | $19.1M | Hold |
473,126
| – | – | 1.79% | 5 |
|
|
2023
Q3 | $12.5M | Buy |
473,126
+43,440
| +10% | +$1.15M | 1.5% | 6 |
|
|
2023
Q2 | $7.39M | Sell |
429,686
-165,000
| -28% | -$2.84M | 1.18% | 11 |
|
|
2023
Q1 | $9.86M | Buy |
+594,686
| New | +$9.86M | 2.24% | 5 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 74 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 109 |
|
|
2022
Q1 | – | Sell |
-1,500
| Closed | -$25K | – | 161 |
|
|
2021
Q4 | $25K | Buy |
+1,500
| New | +$25K | ﹤0.01% | 144 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 113 |
|
|
2020
Q2 | – | Sell |
-87,900
| Closed | -$2.55M | – | 95 |
|
|
2020
Q1 | $2.55M | Buy |
+87,900
| New | +$2.55M | 0.19% | 33 |
|